MKRN1 expression correlated with the tumour, node, and metastasis (TNM) stage of the tumour, and was significantly higher in patients with stages III–IV than in patients with stages I–II cancer (Fig. 1D, P < 0.001). This evidence concerns the gene MKRN1 and cancer.